nuvox_logo 1000 - svg.jpg
  • Pipeline

  • Leadership

  • News

    • Events
  • Publications

    • Acute Hypoxemic Respiratory Failure
    • Hemorrhagic Shock
    • Mechanism Of Action
    • Myocardial Infarction
    • Oncology
    • Pharmacokinetics
    • Stroke
    • Traumatic Brain Injury
  • Careers

  • Contact

  • More

    Use tab to navigate through the menu items.

    Oncology

    A Phase Ib/II clinical trial of DDFPe as a radiosensitizer in glioblastoma

    A Phase Ib/II clinical trial of DDFPe as a radiosensitizer in glioblastoma

    Although small, this trial shows that DDFPe used as a radiosensitizer appears to be safe and may provide some survival benefit.
    TOLD MRI validation of reversal of tumor hypoxia in glioblastoma with a novel oxygen therapeutic

    TOLD MRI validation of reversal of tumor hypoxia in glioblastoma with a novel oxygen therapeutic

    MRI scans indicated that oxygen breathing with DDFPe administration improved tumor oxygenation.
    Reversal of Tumor hypoxia following intravenous delivery of DDFPe

    Reversal of Tumor hypoxia following intravenous delivery of DDFPe

    DDFPe results in a significant increase in intra-tumoral oxygen tension for up to 45 minutes in our pancreatic xenograft model in mice.

    Dynamic Oxygenation Measurements Using a Phosphorescent Coating Window Chamber Model

    Intravenous injection of DDFPe in mice with tumors increases tumor oxygen levels.
    Radiosensitization of Hs-766T Pancreatic Tumor Xenografts in Mice Dosed with DDFPe

    Radiosensitization of Hs-766T Pancreatic Tumor Xenografts in Mice Dosed with DDFPe

    DDFPe administration in mice with pancreatic tumor xenografts resulted in increased tumor oxygen tension lasting up to two hours.
    Radiosensitization of hypoxic tumor cells by DDFPe

    Radiosensitization of hypoxic tumor cells by DDFPe

    DDFP plus carbogen appears to completely reverse the hypoxic cell radioresistance in this rat tumor model.
    • Pipeline
    • Leadership
    • News
      • Events
    • Publications
      • Acute Hypoxemic Respiratory Failure
      • Hemorrhagic Shock
      • Mechanism Of Action
      • Myocardial Infarction
      • Oncology
      • Pharmacokinetics
      • Stroke
      • Traumatic Brain Injury
    • Careers
    • Contact

    NuvOx Pharma

    1635 E 18th Street

    Tucson, Arizona 85719

    ​

    Privacy Policy

    Terms & Conditions

    Company FCOI

    ​

    © 2020 NuvOx Pharma